S2 | E9 | AI-designed medicines to cure rare inherited disease with eMalick Njie - Founder @EcotoneAI

This is the ThinkData podcast in partnership with Dataworks, and in this episode, I spoke with EMalick Njie.

Emalick is the founder of Ecotone AI, a company with a very clear vision –

"To develop AI-based medicines that can cure approximately 10,000 inherited diseases that would have normally been overlooked by the pharmaceutical industry"

He has a fascinating backstory and is seen by many to be a true pioneer in this space.

We had a great discussion about the following:

✔His background and what led him to launch Ecotone

✔Who is Ecotone and what is their mission & vision?

✔What part AI plays in the product

✔What is an LGM(Large Genome Model)

✔The impact that AI can bring to medicine and rare genetic diseases

✔In a highly regulated space such as medicine, how EMalick and Ecotone navigate the various laws and policies in each state and country.

✔Emalick's thoughts on the current state of the generative AI market.

✔What can we expect to see from Ecotone over the coming months?

Click for a recent whitepaper EMalick released - https://emalick.substack.com/p/emergent-populations-derived-with